Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal Yahoo Finance
Covered in this story
What has happened since
- Information Services Group Inc is up 19.6% since this was published, 50 days ago.
- Amgen is up 13.1% since this was published, 50 days ago.
- Novartis is up 4.0% since this was published, 50 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $III yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Information Services Group Inc →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.